Folate-mediated delivery of macromolecular anticancer therapeutic agents.
about
Nanoparticle-facilitated functional and molecular imaging for the early detection of cancerMechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic deliveryFarletuzumab in lung cancerTargeted therapy using nanotechnology: focus on cancerMolecular imaging for cancer diagnosis and surgery.Exploring the tumor microenvironment with nanoparticlesPolymer nanostructures synthesized by controlled living polymerization for tumor-targeted drug deliveryControlled Drug Release from Pharmaceutical NanocarriersFolate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance.Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnologyGold nanoparticles: From nanomedicine to nanosensing.Ultrasonic-activated micellar drug delivery for cancer treatment.A quantitative relaxometric version of the ELISA test for the measurement of cell surface biomarkers.Synthesis of some new porphyrins and their metalloderivatives as potential sensitizers in photo-dynamic therapy.SL2B aptamer and folic acid dual-targeting DNA nanostructures for synergic biological effect with chemotherapy to combat colorectal cancer.Development and evaluation of a new modular nanotransporter for drug delivery into nuclei of pathological cells expressing folate receptors.Anticancer activity of released doxorubicin from a folate-mediated polyelectrolyte complex.Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect.Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery.Bio-orthogonal phosphatidylserine conjugates for delivery and imaging applications.Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer.Design, synthesis, and biological evaluations of tumor-targeting dual-warhead conjugates for a taxoid-camptothecin combination chemotherapy.Development of intrinsically photoluminescent and photostable polylactonesEndocytosis of nanomedicines.A nanoparticle-based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathways.Synthesis, pharmacoscintigraphic evaluation and antitumor efficacy of methotrexate-loaded, folate-conjugated, stealth albumin nanoparticles.The obligatory intestinal folate transporter PCFT (SLC46A1) is regulated by nuclear respiratory factor 1.Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects.Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles.Bioengineering strategies for designing targeted cancer therapiesFolate receptor targeting silica nanoparticle probe for two-photon fluorescence bioimagingMechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release.Cytophilic/cytophobic design of nanomaterials at biointerfaces.Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.Accelerated killing of cancer cells using a multifunctional single-walled carbon nanotube-based system for targeted drug delivery in combination with photothermal therapy.Targeted PDT agent eradicates TrkC expressing tumors via photodynamic therapy (PDT)The role of flexible tethers in multiple ligand-receptor bond formation between curved surfaces.Comparisons of three polyethyleneimine-derived nanoparticles as a gene therapy delivery system for renal cell carcinoma.More effective nanomedicines through particle design
P2860
Q26828849-B0AD78CF-C986-494C-A037-6C49E98EDA24Q26852723-06C80D59-EC12-42B7-A77B-6B1C1401CED1Q26997008-35BCB010-7BB7-4E3F-8F0A-ECA4E155DA54Q27023361-BB5AB08D-44DD-4053-B2C4-C362329770F1Q27687291-FDE5CF6F-C5A9-49B6-8454-4368FC6DDFCCQ28082374-A727AA7B-A0F5-4C3E-8798-29DF60706860Q28085664-337AE0E5-9990-4AE6-9AD3-A527636BF44BQ28257050-2CE04D2C-9772-4B9B-8EF8-89A8D6846FD1Q30365844-EF26C41C-D36B-4A0A-90FB-F136468FDFC2Q30436623-17CD74D0-9167-4757-95B2-642FFFE85151Q30436655-72F742B4-4059-42F2-A7E8-2A96748328D5Q30447539-B69F275E-62C6-4E0E-8EFF-856B56485E7FQ30490995-721F2356-991B-4DD5-A434-5096625D4FA0Q30774704-66811A7E-5AC7-4D2E-A95B-C23BE07C0312Q31037467-B11D2230-70E3-4AFA-95B7-EBDDEDF2B2ADQ33553679-45FBE2FA-1AED-42AD-BA77-CB3C0C8ACC09Q33627894-CCEDB4B2-3B51-4515-B1A0-C9E180A8DD0DQ33631805-17F44862-8921-4AA6-BCC8-5EE8A21AB9F8Q33689872-49681D62-E825-4F85-BCA7-82D39D658278Q33734954-66E7254F-8973-46FD-A9DD-B7E6534F88B8Q33796473-1BD4CC6F-121B-4515-90E5-32C807C2664AQ33812669-3B86D77E-6629-42C2-854A-8B1CC62FDB3DQ33894592-8B8538EE-6923-4FA6-B851-84C0A845E343Q33934257-E798C2E0-B7A8-47FE-B8C7-84087B3FBF83Q33987301-8BFACE6E-6C6C-4D32-8DA6-7A888131D794Q34066773-5B29FCAC-D5E0-45D5-A508-6DF392E58D20Q34075881-8BA44350-4069-4B53-A4DA-EB0493021915Q34132226-54505D81-91DB-418D-89BB-DFFA26161474Q34144898-F2E7ED8E-17BC-458F-8233-5DAA25B1BF73Q34170184-A93A4D5F-C09E-4002-9A6B-B99AE54E665AQ34194191-7E502836-7248-4420-A3C9-5595179F46AAQ34475947-ED1DEA77-1279-4A53-B428-62FC7CB73E5DQ34565264-00C93010-1FFF-4C0C-97BA-E0DFDC788B3BQ34589395-E417831A-C915-4913-9CCC-FB444B95028DQ34658009-161D7E04-A087-4F29-AF53-48CA78648024Q34910276-555F1740-5C6E-4C9D-8AB3-68584C2257BEQ34927053-920CA23A-E4CC-4B85-B487-69B920A0C9ECQ34984732-6940137A-6B17-4D6F-A67F-3333DE8A95BDQ35027211-C2BC9B93-B45D-4842-BB0F-1D97851B6577Q35106115-109B680E-EE02-4034-B235-E352644A0819
P2860
Folate-mediated delivery of macromolecular anticancer therapeutic agents.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Folate-mediated delivery of macromolecular anticancer therapeutic agents.
@ast
Folate-mediated delivery of macromolecular anticancer therapeutic agents.
@en
Folate-mediated delivery of macromolecular anticancer therapeutic agents.
@nl
type
label
Folate-mediated delivery of macromolecular anticancer therapeutic agents.
@ast
Folate-mediated delivery of macromolecular anticancer therapeutic agents.
@en
Folate-mediated delivery of macromolecular anticancer therapeutic agents.
@nl
prefLabel
Folate-mediated delivery of macromolecular anticancer therapeutic agents.
@ast
Folate-mediated delivery of macromolecular anticancer therapeutic agents.
@en
Folate-mediated delivery of macromolecular anticancer therapeutic agents.
@nl
P1476
Folate-mediated delivery of macromolecular anticancer therapeutic agents.
@en
P2093
Philip S Low
Yingjuan Lu
P304
P356
10.1016/S0169-409X(02)00042-X
P407
P577
2002-09-01T00:00:00Z